WO2010128906A1 - Sanitary article with probiotic effect - Google Patents

Sanitary article with probiotic effect Download PDF

Info

Publication number
WO2010128906A1
WO2010128906A1 PCT/SE2009/050491 SE2009050491W WO2010128906A1 WO 2010128906 A1 WO2010128906 A1 WO 2010128906A1 SE 2009050491 W SE2009050491 W SE 2009050491W WO 2010128906 A1 WO2010128906 A1 WO 2010128906A1
Authority
WO
WIPO (PCT)
Prior art keywords
article according
sanitary
absorbent
weight
oxidized
Prior art date
Application number
PCT/SE2009/050491
Other languages
French (fr)
Inventor
Ulla Forsgren Brusk
Chatrine Stridfeldt
Kent Malmgren
Original Assignee
Sca Hygiene Products Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sca Hygiene Products Ab filed Critical Sca Hygiene Products Ab
Priority to PCT/SE2009/050491 priority Critical patent/WO2010128906A1/en
Publication of WO2010128906A1 publication Critical patent/WO2010128906A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/36Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/84Accessories, not otherwise provided for, for absorbent pads
    • A61F13/8405Additives, e.g. for odour, disinfectant or pH control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/84Accessories, not otherwise provided for, for absorbent pads
    • A61F13/8405Additives, e.g. for odour, disinfectant or pH control
    • A61F2013/8408Additives, e.g. for odour, disinfectant or pH control with odour control
    • A61F2013/8435Additives, e.g. for odour, disinfectant or pH control with odour control with plant derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21Acids
    • A61L2300/212Peroxy acids, peracids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera

Definitions

  • the present invention relates to a sanitary article, such as a sanitary napkin, panty liner, incontinence protector, diaper, tampon, wet wipe, tissue or the like, wherein the article provide an enhanced effect against Candida albicans and other unwanted microorganisms.
  • the urogenital area harbors a complex microbial ecosystem comprising more than 50 different bacterial species (Hill et al., Scand. J. Urol. Nephrol. 1984;86 (suppl.) 23-29).
  • the dominating species for fertile women in this area are lactic acid producing bacteria belonging to the genus Lactobacillus. These lactic acid producing members are important for retaining a healthy microbial flora in these areas, and act as probiotic bacteria with an antagonistic effect against pathogenic microbial species.
  • Lactic acid producing bacteria inhibit growth and colonization by other microorganisms by occupying suitable niches for colonization, by forming biofilms and competing for available nutrients, thereby excluding colonization by harmful microorganisms.
  • the production of hydrogen peroxide, specific inhibiting substances, such as bacteriocines, and organic acids (including lactic acid and acetic acid) that lower the phi inhibit the growth and colonization by other microorganisms.
  • the microbial ecosystem of a healthy individual can be disturbed by the use of antibiotics, during hormonal changes, such as during pregnancy or use of contraceptives with estrogen, during menstruation, after menopause, in people suffering from diabetes etc.
  • microorganisms may spread from the anus to the urogenital area, this results in a disturbance of the normal microbial flora and leaves the individual susceptible to microbial infections such as vaginitis, Candida infections, urinary tract infections and skin infections.
  • Microorganisms commonly associated with these kinds of infections belong to the genera Escherichia, Enterococcus, Pseudomonas, Proteus, Klebsiella, Streptococcus, Staphylococcus, Gardnerella and Candida.
  • the skin is colonized by an array of organisms, which forms its normal flora. The numbers and identity of the organisms vary between different skin sites. This, together with the skin's structural barrier, provides the host with an excellent defense against invading microbes.
  • the number of bacteria on the skin varies from a few hundred per cm 2 on the arid surfaces of the forearm and back, to tens of thousands per cm 2 on the moist areas such as the axilla and groin.
  • This normal flora plays an important role in preventing foreign organisms from colonizing the skin, but it too needs to be kept in check, in order to avoid skin infections.
  • Staphylococcus aureus is the most common cause of minor skin infections, such as boils or abscesses, as well as more serious post-operative wound infection. Treatment involves drainage and this is usually sufficient for minor lesions, but antibiotics may be given in addition when the infection is severe and the patient has fever.
  • Toxic shock syndrome is a systemic infection caused by S. aureus strains which produce toxic shock syndrome toxin.
  • the disease came to prominence through its association with tampon use by healthy women, but it is not confined to women and can occur as a result of S. aureus infection at non-genital sites.
  • Streptococcus pyogenes group A streptococci
  • the organisms are acquired through contact with other people with infected skin lesions and may first colonize and multiply on normal skin prior to invasion through minor breaks of the epithelium and the development of lesions.
  • Treatment with penicillin or erythromycin may be necessary to combat the infection.
  • C. albicans is a yeast organism always present in humans but are usually prevented from overgrowth by the indigenous microbial flora.
  • C. albicans likes skin sites which are moist and warm and also rapidly colonizes damaged skin. Hence, the relative dryness of most areas of skin prevents the growth of C. albicans, which therefore are found in low numbers on healthy skin.
  • C. albicans also colonizes the oral and vaginal mucosa and over-growth may result in disease in these sites.
  • C. albicans is associated with diaper dermatitis.
  • a study has shown that C. albicans induced lesions are remarkably influenced by pH, a lower skin pH giving less lesions (B.
  • Dermatophytosis or athlete's foot, is a group of mycosis infections of the skin caused by the parasitic fungi dermophytes Dermatophytosis causes scaling, flaking, and itching of affected areas Dermatophytosis likes warm and moist environments and is typically transmitted in moist areas where people walk barefoot, such as showers or bathhouses
  • lactic acid producing bacteria can be delivered via absorbent products, such as diapers, sanitary napkin, incontinence guards, panty liners and tampons, as described in, for example, WO 92/13577, WO 97/02846, WO 99/17813, WO 99/45099 and WO 00/35502
  • One way to apply lactic acid producing bacteria in sanitary articles is to disperse the bacteria in a hydrophobic carrier in order to protect them from moisture and thus a too early activation as e g described in EP 1 3 22 246
  • the hydrophobic carrier may be fatty acids according to EP 1 3 22 246
  • GB 1 282 889 discloses a deodorant composition
  • a deodorant composition comprising at least one calcium, aluminium, magnesium or zinc salt of an unsaturated aliphatic hydroxycarboxylic acid having at least 17 carbons It is said that the zinc salt may show a fungistatic activity It is further told that these metal salts can be combined with saturated aliphatic hydroxycarboxylic acids and unsaturated aliphatic hydroxycarboxylic acids
  • the saturated hydroxycarboxylic acids may either be naturally saturated or derived from oxidation products of unsaturated fatty acids, such as oleic acid, ricinoleic acid, linoleic acid and linolenic acid.
  • the present invention relates to sanitary articles, such as sanitary napkins, panty liners, incontinence protectors, diapers, hygiene tissues, wherein to the article probiotic bacteria and at least one oxidized lipid has been added in order to inhibit the growth of unwanted microorganisms and give an improved probiotic effect.
  • oxidized lipids have a selective effect against Candida albicans and other unwanted microorganisms, and that a combined use of oxidized lipids and probiotic bacteria gives a very effective inhibition of Candida albicans or other unwanted microorganisms.
  • the oxidized lipids effectively suppress the proliferation of Candida albicans and other unwanted microorganisms such as E. faecalis, E. coli and P. mirabilis while the probiotic beneficial bacteria remains essentially unaffected.
  • the combined use of the probiotic bacteria and the oxidized lipid will thus result in a decreased number of unwanted microorganisms and further also an increased number of established probiotic beneficial bacteria in the microflora of the user of the sanitary article.
  • the lipids have been oxidized under controlled conditions.
  • the oxidized lipids have a peroxide value as measured by AOCS Official Method Cd 8-53 of at least 20, preferably at least 30 and more preferably at least 40 meq/kg.
  • oxidized lipids are oxidized by treatment with ozone.
  • the lipids are fatty acids or derivatives thereof.
  • the fatty acid derivatives are esters of fatty acids, especially triglycerides.
  • At least part of the fatty acids and/or fatty acid derivatives are unsaturated.
  • said probiotic bacteria are lactic acid producing bacteria.
  • said sanitary article comprises 10 5 to 10 11 CFU, preferably 10 8 to 10 10 CFU of probiotic bacteria.
  • the sanitary articles is an absorbent article such as a sanitary napkin, a panty liner, an incontinence protectors, a diaper or a tampon, wherein said absorbent article comprises an absorbent core.
  • said absorbent core comprises hydrophilic fibers treated with said oxidized lipids.
  • said hydrophilic fibers are cellulose fibers.
  • the oxidized lipids in one aspect of the invention it has been added at least 0.05% by weight of the oxidized lipids to said absorbent core, calculated on the total weight of the hydrophilic fibers contained in the absorbent core. In a still further aspect it has been added between 0.05 and 20% by weight, preferably between 0.2 and 15% by weight, more preferably between 0.5 and 10% by weight and most preferably between 1 and 5% by weight of the oxidized lipids to said absorbent core, calculated on the total weight of the hydrophilic fibers contained in the absorbent core.
  • the absorbent article further comprises a fluid impervious backsheet, a liquid-pervious topsheet and/or one or more additional functional layers selected from: liquid receiving layers, liquid distribution layers.
  • At least one oxidized lipid has been added to the topsheet and/or to at least one of said additional functional layers.
  • at least 0.05% by weight of the oxidized lipids has been added to said topsheet or additional functional layer, calculated on the total weight of said topsheet and/or additional functional layer.
  • between 0.05 and 20% by weight, preferably between 0.2 and 15% by weight, more preferably between 0.5 and 10% by weight and most preferably between 1 and 5% by weight of the oxidized lipids has been added to said topsheet and/or additional functional layer, calculated on the total weight of the topsheet and/or additional functional layer.
  • probiotic bacteria have been added to the topsheet.
  • said sanitary articles is a hygiene tissue, such as a wet wipe, dry wipe, wash cloth, patch, towelette or napkin.
  • said hygiene tissue contains between 0.001 and 15 g/g, preferably between 0.01 and 8 g/g, more preferably 0.05 g/g and 4 g/g and most preferably between 0.1 and 3 g/g of added oxidized lipids calculated on the total weight of the hygiene tissue.
  • Fig. 1 is a schematic plan view of an absorbent article in the form of a sanitary napkin or incontinence guard.
  • Fig. 2 is a cross section according to the line M-Il in Fig. 1.
  • Fig. 3 is a schematic plan view of a hygiene tissue.
  • Fig. 4 shows the survival of LB931 in synthetic urine added to absorbent cores with different additions of ozonized sunflower oil.
  • Fig. 5 shows the survival of LB87b in synthetic urine added to absorbent cores with different additions of ozonized sunflower oil.
  • Fig. 6 shows the survival of Ess1 in synthetic urine added to absorbent cores with different additions of ozonized sunflower oil.
  • Fig. 7 shows the survival of LB931 and Candida albicans in synthetic urine added to treated and untreated absorbent cores.
  • Fig. 8 shows the survival of LB931and C. albicans 702 in synthetic urine added to untreated absorbent cores and absorbent cores treated with 3 % ozonized olive oil.
  • Fig. 9 shows the survival of LB87b and C. albicans 702 in synthetic urine added to untreated absorbent cores and absorbent cores treated with 3 % ozonized olive oil.
  • sanitary article refers to products that are placed against the skin of the wearer to absorb and contain body exudates, like urine, faeces and menstrual fluid, and also to products that are used for cleaning and caring of the skin and the urogenital area and that also can be used to deliver probiotic bacteria and oxidized lipids to these areas.
  • the invention mainly refers to disposable sanitary articles, which means articles that are not intended to be laundered or otherwise restored or reused as a sanitary article after use.
  • disposable sanitary articles examples include wet wipes, dry wipes, feminine hygiene products such as sanitary napkins, panty liners, sanitary panties and tampons; diapers and pant diapers for infants and incontinent adults; incontinence pads; diaper inserts and the like.
  • absorbent article refers to products that are placed against the skin of the wearer to absorb and contain body exudates, like urine, faeces and menstrual fluid.
  • the invention mainly refers to disposable absorbent articles, which means articles that are not intended to be laundered or otherwise restored or reused as an absorbent article after use.
  • disposable absorbent articles include feminine hygiene products such as sanitary napkins, panty liners and sanitary panties; diapers and pant diapers for infants and incontinent adults; incontinence pads; diaper inserts and the like.
  • honeygiene tissue any device for wiping, cleaning and caring of the skin and the urogenital area which also can be used to deliver probiotic bacteria and oxidized lipids to these areas, for instance a wet wipe, dry wipe, washcloth, patch, towelette, napkin, and the like.
  • lipid denotes all fat-soluble (lipophilic), naturally-occurring substances, such as fats, oils, waxes, cholesterol, steroids, monoglycerides, diglycerides, triglycerides, phospholipids, and others.
  • oxidized lipids is meant that the lipids have undergone an oxidation process wherein oxygen has been introduced in the lipid molecular structure.
  • the oxidation agent is any agent, which leads to oxidation of the lipid structure, e.g. oxygen gas, ozone or peroxides.
  • oxidized under controlled conditions is meant that the substrate, i.e. the lipid has been oxidized to a degree wherein further oxidation caused by autoxidation from contact with air is substantially prevented.
  • the lipids have been oxidized so that they have a peroxide value as measured by AOCS Official Method Cd 8-53 of at least 20 meq/kg.
  • probiotic bacteria live microorganisms that confer a health benefit when administered in adequate amounts to a host.
  • Fig. 1 and 2 show an embodiment of an absorbent article in the form of a sanitary napkin or an incontinence guard 1 intended to be worn as an insert in a pair of pants.
  • the article 1 typically comprises a liquid permeable topsheet 2, a liquid impermeable backsheet 3 and an absorbent core 4 enclosed therebetween.
  • the article has a longitudinal direction, y, and a transverse direction, x. It has a pair of longitudinal side edges 6 and 7 and a pair of transverse edges 8 and 9.
  • the liquid permeable topsheet 2 can be composed of a nonwoven material, e g spunbonded, meltblown, carded, hydroentangled, wetlaid etc.
  • Suitable nonwoven materials can be composed of natural fibers, such as woodpulp or cotton fibres, manmade fibres, such as polyester, polyethylene, polypropylene, viscose etc. or from a mixture of natural and manmade fibres.
  • the topsheet material may further be composed of tow fibres, which may be bonded to each other in a bonding pattern, as e.g. disclosed in EP- A- 1 035 818.
  • Further examples of topsheet materials are porous foams, apertured plastic films etc.
  • the materials suited as topsheet materials should be soft and non-irritating to the skin and be readily penetrated by body fluid, such as urine or menstrual fluid.
  • the liquid impermeable backsheet 3 may consist of a thin plastic film, e.g. a polyethylene or polypropylene film, a nonwoven material coated with a liquid impervious material, a hydrophobic nonwoven material, which resists liquid penetration or laminates of plastic films and nonwoven materials.
  • the backsheet material may be breathable so as to allow vapour to escape from the absorbent core, while still preventing liquids from passing through the backsheet material.
  • the topsheet 2 and the backsheet material 3 have a somewhat greater extension in the plane than the absorbent core 4 and extend outside the edges thereof.
  • the layers 2 and 3 are connected to each other within the projecting portions 5 thereof, e g by gluing or welding by heat or ultrasonic.
  • the topsheet and/or the backsheet may further be attached to the absorbent core by any method known in the art, such as adhesive or welding by heat or ultrasonic etc.
  • the absorbent core may also be unattached to the topsheet and/or the backsheet.
  • a fastening means in the form of a region 10 of an adhesive is provided on the side of the backsheet facing away from the wearer in use.
  • the adhesive may releasably attach to the undergarment of the wearer.
  • a release paper 1 1 protects the adhesive region before use.
  • the adhesive region 10 may have any suitable configuration, such as elongate or transverse strips, dots, full-coated areas etc.
  • absorbent articles in other embodiments of absorbent articles according to the invention other types of fasteners, like friction fasteners, tape tabs or mechanical fasteners like hook-and-loop fasteners etc may be used to fasten the articles to the underwear or around the waist of the wearer.
  • Some absorbent articles are in the form of pants and therefore do not need special fastening means. In other cases the absorbent article is worn in special elastic pants without the need for additional fasteners.
  • the absorbent core 4 can be of any conventional kind. Examples of commonly occurring absorbent materials are cellulosic fluff pulp, tissue layers, highly absorbent polymers (so called superabsorbents), absorbent foam materials, absorbent nonwoven materials or the like. It is common to combine cellulosic fluff pulp with superabsorbents in an absorbent core. It is also common to have absorbent bodies comprising layers of different material with different properties with respect to liquid acquisition capacity, liquid distribution capacity and storage capacity. This is well-known to the person skilled in the art and does therefore not have to be described in detail. The thin absorbent bodies, which are common in today ' s absorbent articles, often comprise a compressed mixed or layered structure of cellulosic fluff pulp and superabsorbent material. The size and absorbent capacity of the absorbent core may be varied to be suited for different uses such as sanitary napkins, pantiliners, adult incontinence pads and diapers, baby diapers, pant diapers, etc.
  • Fig. 3 shows an embodiment of a hygiene tissue.
  • the hygiene tissue 12 provided can be composed of a matrix comprising any natural or synthetic fiber, such as rayon, cellulose, regenerated cellulose, polyester, polyolefine fibers, textile and the like, or foam, nonwoven, felt or batting, or combinations thereof.
  • the object of the present invention is to provide sanitary articles, such as sanitary napkins, panty-liners, diapers, incontinence guards, hygiene tissues etc. suitable for absorbing bodily fluids exudates and/or cleaning and caring of the skin and the urogenital area and simultaneously release probiotic bacteria and an oxidized lipid that is to be transferred to the skin, or alternatively, in order to inhibit the growth of unwanted microorganisms in the sanitary article itself during use of the article.
  • sanitary articles such as sanitary napkins, panty-liners, diapers, incontinence guards, hygiene tissues etc. suitable for absorbing bodily fluids exudates and/or cleaning and caring of the skin and the urogenital area and simultaneously release probiotic bacteria and an oxidized lipid that is to be transferred to the skin, or alternatively, in order to inhibit the growth of unwanted microorganisms in the sanitary article itself during use of the article.
  • oxidized lipids have a selective effect against Candida albicans and other unwanted microorganisms, and that a combined use of oxidized lipids and probiotic bacteria gives a very effective inhibition of Candida albicans or other unwanted microorganisms.
  • the oxidized lipids effectively suppress the proliferation of Candida albicans and other unwanted microorganisms such as E. faecalis, E. coli and P. mirabilis while the probiotic beneficial bacteria remains essentially unaffected.
  • the combined use of the probiotic bacteria and the oxidized lipid will thus result in a decreased number of unwanted microorganisms and further also an increased number of established probiotic beneficial bacteria in the microflora of the user of the sanitary article.
  • probiotic bacteria which are suitable for use in the present invention produce acid and are non-pathogenic. There are many suitable bacteria identified herein below, although the invention is not limited to currently known bacterial species and strains as long as the above function and the objectives of the bacteria are fulfilled.
  • An important characteristic of these bacteria is their capability to produce acid, said acid increases the acidity of the skin mucosa which helps in preventing the growth, colonization and survival of undesired fungi and bacteria.
  • these probiotic bacteria inhibit the growth of competing and harmful bacteria and fungi.
  • Further important characteristic of said bacteria is their ability to produce hydrogen peroxide and other microbe inhibiting substances and also their ability to adhere to cell surfaces and thereby prevent adhesion of other harmful bacteria to these surfaces.
  • Typical lactic acid-producing bacteria useful in a microbe-inhibiting composition of this invention are all members of the Lactobacillus, Lactococcus or Pediococcus, which are efficient acid producers, and also including non-pathogenic members of the Bacillus genus, all members of the Bifidobacterium genus, and Pseudomonas limbergii, although certain species are especially preferred as described below.
  • Lactobacillus genus examples include Lactobacillus acidophilus
  • Lactobacillus brevis Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus cereale, Lactobacillus delbrukeii, Lactobacillus fermentum, Lactobacillus gaserii, Lactobacillus jensenii, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus salivarius, Lactobacillus thermophilus, Lactobacillus paracasai sp. paracasai, Lactobacillus crispatus, Lactobacillus helveticus, Lactobacillus lactis, and the like.
  • Lactobacillus fermentum Ess-1 and Lactobacillus plantarum LB 931.
  • Ess-1 has previously been found valuable for preventing and/or treating Candida infections as it inhibits growth of Candida albicans and several other harmful microorganisms, as disclosed in WO 2008060198.
  • LB 931 has shown to be particularly effective for preventing and/or treating other urogenital infections, as disclosed in e.g. EP1060240.
  • a sanitary article of the present invention typically comprises lactic acid producing bacteria in amounts of about 10 5 - 10 11 CFU (colony forming units) of viable probiotic acid- producing bacteria per article.
  • the bacteria may be in the form of cells or spores which are provided in a suspension which is applied to the sanitary article which is thereafter dried.
  • the bacteria may also be freeze dried and dispersed in a hydrophobic carrier, in order to protect the bacteria from ambient moisture, before being added to the sanitary article.
  • the sanitary article will comprise about 10 8 - 10 10 CFU per sanitary article, although these amounts may vary depending on the specific application, product formulation and intended use.
  • oxidized lipids are very effective in reducing Candida albicans and other unwanted microorganisms.
  • Natural animal-derived or plant-derived lipids are very often mixtures of mono-, di- and triglycerides and free fatty acids.
  • the lipids can be purified, hydrated, refined, modified and used individually or in different mixtures. Examples of suitable lipids which originate from animals can be found in bees waxes, emu oil, lactis lipida, lanolin, shark's liver oil, lard, whale oil, butter fat and tallow.
  • lipids which originate from plants can be found in apricot kernel oil, ground nut oil, avocado oil/wax, blackcurrant seed oil, borage seed oil, Brazil nut oil, castor oil, cacao butter, cocoa butter, coconut butter, coconut oil, maize oil, cotton seed oil, rose hip seed oil, evening primrose oil, grape seed oil, linseed oil, mango seed oil, rose oil, olive oil, orange wax, palm oil, ground nut oil, rice wax, sesame seed oil, shea butter, soybean oil, sunflower oil, sunflower seed wax, peanut oil, sesame oil, safflower oil, theobroma oil, tobaccoseed oil, poppyseed oil, teased oil, kapok oil, rice bran oil, sorghum oil, crambe oil, linseed oil, perilla oil, hempseed oil, tung oil, oiticica oil, palm kern oil, sweet almond oil and wheat germ oil.
  • lipids are phospholipids and waxy oils,
  • Triglycerides are commonly occurring in many natural fats and oils. Most of the naturally occurring triglycerides contain a mixture of saturated and unsaturated fatty acids, while the proportion of saturated and unsaturated fatty acids varies between the different oils. This proportion can be given as the quotient: unsaturated/saturated.
  • the unsaturated fatty acids may either be monounsaturated or polyunsaturated.
  • the most commonly occurring fatty acids in triglycerides are palmitic acid, a saturated fatty acid, oleic acid, a monounsaturated fatty acid, linoleic and linolenic acids, which are polyunsaturated fatty acids.
  • Table 1 is taken from Bailey ' s Industrial Oil and Fat products, vol.1 , editor: Daniel Swern, John Wiley & Sons Inc., New York,1979.
  • oils and fats normally contain antioxidants, either naturally occurring or added by a supplier, so that autoxidation caused by contact with air is substantially prevented or delayed.
  • the lipids used in the present invention are oxidized by an oxidizing agent.
  • oxidizing agents are: ozone, peroxides, oxygen gas, peroxy acids and nitrogen dioxide.
  • ozone peroxides
  • oxygen gas peroxy acids
  • nitrogen dioxide peroxides
  • 15 oxygen or air i.e. autoxidation under a sufficient time period
  • the oxidation should preferably be performed under controlled conditions, so that after the oxidation process autoxidation is substantially prevented.
  • the oxidized lipids should have a peroxide value as measured by AOCS Official Method Cd 8-53 of at least 20, preferably at least 30 and more preferably at least 40 meq/kg.
  • the lipids may be oxidized by any suitable method and by any suitable oxidation agent, for example by ozone, mixtures of ozone/air or ozone/oxygen.
  • a series of peroxidic products may be formed, such as hydroperoxides, ozonides, diperoxides, peroxides and polyperoxides.
  • Certain by-products may also be formed, for example ketones and aldehydes, which are less desired.
  • These by-products may be removed by extracting the lipids with a solvent after the oxidation process.
  • volatile undesired substances may be removed by evaporation, for example under vacuum.
  • a further possibility is to selectively remove said undesired substances by adsorption.
  • pulp treated with oxidized lipids, especially ozonized triglycerides have a significant ability to inhibit the growth of Candida albicans and other unwanted microorganisms such as E. faecalis, E. coli and P. mirabilis.
  • the amount of oxidized lipids added should be at least 0.05% of the total weight of the treated pulp.
  • the treated pulp may be mixed with untreated pulp and/or with superabsorbent material to form an absorbent core 4.
  • An absorbent core can contain between 0.05 and 20% by weight, preferably between 0.2 and 15% by weight, more preferably between 0.5 and 10% by weight and most preferably between 1 and 5% by weight of added oxidized lipids calculated on the total weight of the hydrophilic fibers, for example pulp fibers, contained in the absorbent core.
  • the oxidized lipids may thus be added to the pulp, usually cellulosic fluff pulp, used in the absorbent core 4 of an absorbent article. Alternatively or in addition they may be added to the topsheet 2 or any additional functional layer contained in the absorbent article, such as liquid receiving layer, liquid distribution layer, liquid storage layer etc.
  • At least a part of the treated pulp fibers in the core can be distributed only to certain areas in the absorbent core 4.
  • the treated pulp fibers are distributed or positioned in areas in the form of spaced apart islands.
  • the proportion by weight of the hydrophobic microbe-inhibiting material in the aforementioned islands in the core can be 25-35 % by weight, calculated in relation to the total weight of the hydrophilic fibrous material in the core in the areas or the islands.
  • the proportion by weight of oxidized lipids can be higher compared with the situation in which the oxidized lipids are uniformly distributed in a core, since a greater proportion by weight of liquid-absorbent fibers is present in adjacent parts of the liquid-absorbent core in order to compensate for impaired liquid absorption by the treated pulp fibers in the areas.
  • the treated fibers can be mixed with other fibers and/or with superabsorbent material in different proportions.
  • the proportion of oxidized lipids should not be too high in the wetting area, because they may impair the absorption capacity of body liquid.
  • the wetting area is located essentially in the central crotch part of the absorbent article.
  • the oxidized lipids in the same manner as in the absorbent core 4, can be uniformly distributed in any other layer in the absorbent article, such as the topsheet, a liquid receiving layer, a liquid distribution layer or the like.
  • the proportion by weight of the oxidized liquid in these layers can be the same as for the absorbent core.
  • the oxidized lipids can also be distributed in certain areas of these layers in the same way as described with respect to the absorbent core.
  • the proportion of oxidized lipids may vary.
  • the oxidized lipids can be added to the pulp fibers, or other fibers, in conjunction with the production of the fibers or be added in the production apparatus in which the absorbent articles are produced.
  • the lipids may either be oxidized before being added to the fibers or after addition.
  • the fibers, for example pulp fibers are treated with the lipids and the treated pulp is then reacted with the oxidizing agent, for example ozone.
  • the ozone may then at the same time act as a bleaching agent for the pulp.
  • the amount of oxidized lipids added may vary dependant on the intended use.
  • oxidised lipids may be used in the urogenital area, where it is an advantage that the lipids remain on the skin, than in hand or foot wiping, where it may be desired that only small amounts of the lipids may remain.
  • the hygiene tissue can contain between 0.001 and 15 g/g, preferably between 0.01 and 8 g/g, more preferably between 0.05 and 4 g/g and most preferably between 0.1 and 3 g/g of added oxidized lipids calculated on the total weight of the hygiene tissue.
  • the amounts may differ dependant on the intended use.
  • the probiotic bacteria and the oxidized lipid are preferably transferred and delivered to the skin thereby serving as a skin treatment agent.
  • the oxidized lipids and the probiotic bacteria may be added separately or premixed to hygiene tissue. If the oxidized lipids and the probiotic bacteria are added separately they may be distributed evenly throughout the hygiene tissue. Alternatively, the oxidized lipids and the probiotic bacteria may be localized in specific areas of the hygiene tissue, especially on the surface thereof, so as to be easily released from the hygiene tissue and transferred to the skin. When the oxidized lipids and the probiotic bacteria are localized in specific areas of the hygiene tissue, the oxidized lipids and the probiotic bacteria may be added separately to the hygiene tissue on different locations of the hygiene tissue.
  • One or more of the following components may be added to the hygiene tissue together with the oxidized lipid: a viscosity regulating agent, a carrier for the oxidized lipid or an agent for improving the adhesion of the composition to the skin.
  • Quaternary tensides may be used as agents for improving the adhesion to skin.
  • Other components which may be contained in the composition are cleaning agents, skin care agents, fragrances etc. Furthermore, it is important to keep the water activity of the composition very low in order to secure the survival of the probiotic bacteria.
  • the lipids may either be oxidized before being added to the fibers or after addition.
  • the ozone may then at the same time act as a bleaching agent for the pulp, in case pulp fibres are present in the wipe.
  • the carrier material used in the hygiene tissue should be chosen so that it can hold the oxidized lipids in its porous structure and release it to the skin when the wipe is used.
  • suitable carrier materials are fibrous materials such as tissue paper, airlaid tissue and different type of nonwoven materials.
  • nonwoven materials are hydroentangled webs, spunbond, meltblown, thermobonded webs etc.
  • Further examples of carrier materials are foams, nets, films etc.
  • the oxidised lipids may be applied between film layers and exposed when separating the film layers from each other and/or applied in formed recesses in the film.
  • the structure of the carrier material is important for its function to hold liquid substances.
  • a material that is especially suitable in this respect is hydroentangled webs.
  • Fibres that are useful in fibrous carrier materials are pulp fibres, cotton fibres, bamboo fibres and other natural fibres, regenerated cellulose fibres such as viscose and lyocell as well as syntethic polyolefin fibres, like polyethylene and polypropylene, polyester and mixtures thereof.
  • a suitable fiber composition may be a mixture of viscose fibers and polyester fibers, for example 70 wt% viscose fibers and 30 wt% polyester.
  • a common fiber composition in other type of wipes is a mixture of pulp fibers and polypropylene.
  • a suitable basis weight for a personal hygiene wipe is between 30 and 70 g/m 2 , preferably between 40 and 50 g/m 2 .
  • the size of the hygiene tissues may vary depending on its intended use. Examples of suitable sizes are 10x15 cm, 12x20 cm and 16x18 cm.
  • composition comprising the oxidized lipids may be added to the carrier material by spraying, coating and impregnation.
  • the probiotic bacteria may be added to the topsheet, to the absorbent core or to an acquisition layer, being interposed between the topsheet and the absorbent core.
  • the oxidized lipids and the probiotic bacteria may be added separately or premixed to the absorbent article.
  • the probiotic bacteria may be added to a different location than the oxidized lipids or to the same location as the oxidized lipids. In order to achieve a good transfer to the user, the topsheet is preferred.
  • the ozone was generated in an Argenotox ozone generator, type GL, Hamburg, operated at a voltage of 150V an inlet oxygen flow of 63 l/h. 200 g of each tested oil/fat was treated during a time period of 2h with an ozone/oxygen flow of 0.061 g/min. The ozone concentration of the added gas was 58 g/m 3 .
  • the gas was bubbled through the oil which was contained in a vented vessel.
  • a magnetic stirrer was used in the vessel.
  • the solid fats were gently heated above melting temperature, after which the gas was bubbled through the liquid fats.
  • the tested oils/fats are those stated in Table 3 below.
  • Test liquid 1 Sterile, synthetic urine to which a growth medium for microorganisms had been added.
  • the synthetic urine contained monovalent and divalent cations and anions and urea and had been produced in accordance with the information in Geigy, Scientific Tables, vol. 2, 8th ed., 1981 , page 53.
  • the growth medium for the microorganisms is based on two common growth media, Hook and FSA medium for enterobacteria. The pH in this mixture was 6.6.
  • the solution contained 43% ozonized oil/fat and 57% hexane.
  • the solution was equally distributed over the surface of the sheets.
  • About 5 gram of liquid was added per 5 gram of pulp.
  • the sheets contained 30% by weight oil/fat and 70% by weight pulp fibers.
  • the treated sheets were defibrated in a Braun multimixer MX32 to produce fluff pulp.
  • a homogenous mixture of fluffed pulp was prepared in the following way (Method 1 ): Untreated and treated Weyerhauser pulp (NB416) was weighed in desired proportions and put in Braun multimixer, MX32. The pulp was mixed about 30 seconds.
  • Absorbent cores for testing were produced in the following way (Method 2): Absorbent cores were prepared using a slightly modified sample former according to SCAN C 33:80. Fluffed pulp of the desired type(s) was weighed and a homogeneous mixture of the fluffed pulp(s) was introduced into a flow of air having a negative pressure of approximately 75mbar, through a pipe having a diameter of 10 mm and being equipped at the bottom with a metal net. The fluff pulp was gathered on the metal net and thereafter constituted the absorbent specimen. The absorbent core was compressed to a bulk within the range of 6 to 12 cm 3 /g.
  • absorbent cores Two different types were produced; the reference cores were composed of 2.Og untreated Weyerhauser pulp (NB 416) and the test cores were composed of a mixture of 1.4g treated Weyerhauser pulp (NB 416), treated with oxidized sunflower oil (30 weight% oil), peroxide value 65.5 meq./kg, according to the method described under "Treatment of pulp with oils/fats" above and 1.Og of untreated
  • test cores contained 15% ozonized sunflower oil.
  • size of the absorbent cores was 5 cm in diameter.
  • the bacterial growth in the absorbent cores was measured in the following way: Bacteria were cultured in nutrient broth and diluted in test liquid 1 to the desired concentration of ca. 10 3 3 cfu/ml (colony forming units/ml). 10 ml of test liquid 1 containing bacteria were added to the test cores and each of the cores were placed in a sterile jar (Nunc sputum/organ jars, 100 ml), and lids was fitted on the jars. The jars was turned upside down and incubated in a warm cabinet at 35°C.
  • the absorbent cores were each placed in a plastic bag with 90 ml peptone water and the content was homogenized (agitated and worked up) in a congressker for 3 minutes.
  • the homogenate was diluted in dilution tubes with peptone water and a microbiological culture was spread on agar plates. Slanetz Bartley agar was used for E. faecalis, and Drigalski agar for E. coli and P. mirabilis.
  • the specimens were incubated at 35 0 C for 1-2 days before the colonies were counted. The result is shown in Table 5, which clearly illustrates an reduction of all 3 test bacteria in the test cores after 6 and 12 hours, compared with the reference core in which all the bacteria grew well.
  • Sheets of bleached kraft pulp produced by the company Weyerhaeuser, NB416, were fluffed in a laboratory hammermill. Sheets of the same pulp grade were also impregnated with ozonized oil. 1.6 of ozonized sunflower oil with a peroxide value of 276.9 meq./kg was dissolved in 23.4 g acetone. This solution was then thoroughly distributed over a sheet of NB416, weighing 25 g. The solution ws rapidly absorbed by the pulp and seemed to be homogeneously distributed. After 4 h, the acetone h evaporated and a pulp sheet containing 6 % ozonized sunflower oil had been prepared.
  • the sheet was first torn by hand to pieces with a size of about 2 cm * 2 cm and then about 5 g pulp at the time was agitated in the mixer at maximum intensity for about 30 s. After this treatment of the two samples, fluffed pulps with 6 % resp. 30 % ozonized sunflower oil hac been prepared.
  • Pads of fluffed pulp were prepared by mixing untreated, fluffed NB416 and fluffed NB416 containing ozonized sunflower oil. Each pad contained 2 g pulp and different amounts of ozonized sunflower oi
  • Sample 2. 1 ,03 g untreated, fluffed NB416 and 1 ,03 g fluffed NB416 containing 6 % ozonized sunflower oil
  • Sample 3 1 ,18 g untreated, fluffed NB416 and 1 ,18 g fluffed NB416 containing 30 % ozonized sunflower oil
  • sample 1 contained just pulp fibres
  • sample 2 contained 3 % ozonized sunflower oil
  • sample 3 contained 15 % ozonized sunflower oil.
  • Each sample was then mixed in the Braun Multimixer for 10 s at maximum intensity to achieve homogeneous fibre mixtures. These fibre mixtures were then used for preparation of circular, 0 5 cm, pads using a PFI test piece former. Thi: equipment is described in the standard method SCAN-C 33:80. The test pieces were then compressed with a load of 16 kPa for 10 s., which resulted in a density of 10-15 cm 3 /g. 12 test piece of each sample were prepared.
  • the survival of LB931 and LB87b was measured in the following way.
  • the lactobacilli were cultured in MRS broth to stationary phase.
  • the suspension of each strain was diluted in test liquid 1 to a concentration of about 10 4 - 10 45 CFU/ml.
  • test liquid 1 containing LB931 and LB87b respectively 10 ml of test liquid 1 containing LB931 and LB87b respectively was added to the treated and the untreated absorbent cores, respectively, each placed in a sterile plastic jar, and the jars were covers with plastic lids. Two samples were prepared for each bacteria and absorbent core. The jars were incubated in a warm cabinet at 37 0 C. After incubation for 0 and 4 hours, the absorbent cores were each placed in a plastic bag with 20ml saline solution and the content was homogenized (agitated a worked up) in a stomacher for 3 minutes at high speed. The homogenate was diluted in dilution tube with saline solution and the suspension was spread on Rogosa agar plates. The plates were incubated at 37°C in 5% CO 2 for 2 days before the colonies were counted.
  • Sample 2. 1 ,03 g untreated, fluffed NB416 and 1 ,03 g fluffed NB416 containing 6 % ozonized sunflower oil. This means that sample 2 in total contained 3% ozonized sunflower oil.
  • the suspension of Ess-1 was diluted in test liquid 1 to a concentration of about 10 35 - 10 45 CFU/ml.
  • Test liquid 1 as described above was prepared for the growth measurements.
  • Fluffed pulp was prepared according to Method 1 and absorbent cores were prepared according to Method 2.
  • the oxidised oil was in this case oxidised sunflower oil having a peroxide value of 276.9 mmol/kg according to the method described under "Treatment of pulp with oils/fats" with the exception that acetone was used to dissolve the ozonized sunflower oil instead of hexane. This means that the untreated absorbent core contained just pulp fibres and the treated absorbent core contained 15% ozonized sunflower oil.
  • LB931 and Candida albicans were cultured in MRS and Todd Hewitt-broth respectively to stationary phase.
  • the suspensions were diluted in test liquid 1 to a concentration of about 3,5x10 4 cfu/ml for LB931 and about 6,0x10 3 cfu/ml for C. albicans.
  • test liquid 1 containing Candida and LB931 respectively 10 ml of test liquid 1 containing Candida and LB931 respectively was added to the treated and untreated absorbent cores, respectively, placed in a sterile plastic jar, and the jar was covered with aluminium foil. Two samples were prepared for each microorganism and absorbent core. The jars were incubated in a warm cabinet at 37 0 C. After incubation for 0, 4, 6 and 8 hours, the absorbent cores were each placed in a plastic bag with 20ml saline solution and the content was homogenized (agitated and worked up) in a stomacher for 3 minutes at high speed. The homogenate was diluted in dilution tubes with saline solution and the suspension was spread on agar plates. Sabaroud-dextrose agar was used for Candida and MRS agar for LB931. The plates were incubated at 37 0 C (in 5% CO 2 for MRS plates) for 2 days before the colonies were counted.
  • Sheets of bleached kraft pulp produced by the company Weyerhaeuser, NB416, were fluffed in a laboratory hammermill. Sheets of the same pulp grade were also impregnated with ozonized oil. 1.6 g of ozonized olive oil with a peroxide value of 263.8 meq./kg was dissolved in 23.4 g acetone. This solution was then thoroughly distributed over a sheet of NB416, weighing 25 g. The solution was rapidly absorbed by the pulp and seemed to be homogeneously distributed. After 4 hours the acetone had evaporated and a pulp sheet containing 6 % ozonized olive oil had been prepared.
  • the pulp sheet containing 6 % ozonized olive oil was fluffed in a Braun Multimixer MX 32.
  • the sheet was first torn by hand to pieces with a size of about 2 cm * 2 cm and then about 5 g pulp at the time was agitated in the mixer at maximum intensity for about 30 s. After this treatment of the sample, fluffed pulp with 6 % ozonized olive oil had been prepared.
  • Pads of fluffed pulp were prepared by mixing untreated, fluffed NB416 and fluffed NB416 containing ozonized olive oil. Each pad contained 2 g pulp and different amounts of ozonized olive oil.
  • Sample 2. 1 ,03 g untreated, fluffed NB416 and 1 ,03 g fluffed NB416 containing 6 % ozonized olive oil
  • sample 1 contained just pulp fibres and sample 2 contained 3 % ozonized olive oil.
  • sample 2 contained 3 % ozonized olive oil.
  • Each sample was then mixed in the Braun Multimixer for 10 s at maximum intensity to achieve homogeneous fibre mixtures. These fibre mixtures were then used for preparation of circular, 0 5 cm, pads using a PFI test piece former. This equipment is described in the standard method SCAN-C 33:80.
  • the test pieces were then compressed with a load of 16 kPa for 10 s., which resulted in a density of 10-15 cm 3 /g. 18 test pieces of each sample were prepared.
  • LB931 and Candida albicans were cultured in MRS and Todd Hewitt-broth, respectively, to stationary phase.
  • the suspensions were diluted in test liquid 1 to a concentration of about 10 44 cfu/ml for LB931 and about 10 43 cfu/ml for C. albicans.
  • test liquid 1 containing Candida and LB931 respectively 10 ml was added to the treated and untreated absorbent cores, respectively, which were each placed in a sterile plastic jar.
  • the jar was tightly covered with aluminium foil.
  • Two samples were prepared for each microorganism and each absorbent core.
  • the jars were incubated in a warm cabinet at 37 0 C. After incubation for 0, 2, and 6 hours, the absorbent cores were each placed in a plastic bag with 20ml saline solution and the content was homogenized (agitated and worked up) in a stomacher for 3 minutes at high speed. The homogenate was diluted in dilution tubes with saline solution and the suspension was spread on agar plates.
  • Sabaroud-dextrose agar was used for Candida and Rogosa agar for LB931. The plates were incubated at 37 0 C (in 5% CO 2 for the Rogosa agar) for 2 days before the colonies were counted.
  • LB87b and Candida albicans were cultured in MRS and Todd Hewitt-broth, respectively, to stationary phase.
  • the suspensions were diluted in test liquid 1 to a concentration of about 10 4 7 cfu/ml for LB87b and about 10 47 cfu/ml for C. albicans.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

A sanitary article such as a sanitary napkin, panty liner, diaper, pant diaper, adult incontinence guard, hygiene tissue, wherein the article comprises oxidized lipids and probiotic bacteria. Preferably the lipids are oxidized under controlled conditions to have a peroxide number of at least 20 meq/kg. The lipids are for example triglycerides of fatty acids.

Description

SANITARY ARTICLE WITH PROBIOTIC EFFECT
TECHNICAL FIELD
The present invention relates to a sanitary article, such as a sanitary napkin, panty liner, incontinence protector, diaper, tampon, wet wipe, tissue or the like, wherein the article provide an enhanced effect against Candida albicans and other unwanted microorganisms.
BACKGROUND OF THE INVENTION
The urogenital area harbors a complex microbial ecosystem comprising more than 50 different bacterial species (Hill et al., Scand. J. Urol. Nephrol. 1984;86 (suppl.) 23-29). The dominating species for fertile women in this area are lactic acid producing bacteria belonging to the genus Lactobacillus. These lactic acid producing members are important for retaining a healthy microbial flora in these areas, and act as probiotic bacteria with an antagonistic effect against pathogenic microbial species. Lactic acid producing bacteria inhibit growth and colonization by other microorganisms by occupying suitable niches for colonization, by forming biofilms and competing for available nutrients, thereby excluding colonization by harmful microorganisms. Also, the production of hydrogen peroxide, specific inhibiting substances, such as bacteriocines, and organic acids (including lactic acid and acetic acid) that lower the phi, inhibit the growth and colonization by other microorganisms.
The microbial ecosystem of a healthy individual can be disturbed by the use of antibiotics, during hormonal changes, such as during pregnancy or use of contraceptives with estrogen, during menstruation, after menopause, in people suffering from diabetes etc. Also, microorganisms may spread from the anus to the urogenital area, this results in a disturbance of the normal microbial flora and leaves the individual susceptible to microbial infections such as vaginitis, Candida infections, urinary tract infections and skin infections. Microorganisms commonly associated with these kinds of infections belong to the genera Escherichia, Enterococcus, Pseudomonas, Proteus, Klebsiella, Streptococcus, Staphylococcus, Gardnerella and Candida. Women are at particular risk due to their shorter distance between the anus and the urogenital tract; specially at risk are young women before entering puberty, who not yet have a well developed microflora in the urogenital area, and post-menopausal women, who in most cases no longer have a protective flora. Similarly to the urogenital area, the skin is colonized by an array of organisms, which forms its normal flora. The numbers and identity of the organisms vary between different skin sites. This, together with the skin's structural barrier, provides the host with an excellent defense against invading microbes. The number of bacteria on the skin varies from a few hundred per cm2 on the arid surfaces of the forearm and back, to tens of thousands per cm2 on the moist areas such as the axilla and groin. This normal flora plays an important role in preventing foreign organisms from colonizing the skin, but it too needs to be kept in check, in order to avoid skin infections.
Staphylococcus aureus is the most common cause of minor skin infections, such as boils or abscesses, as well as more serious post-operative wound infection. Treatment involves drainage and this is usually sufficient for minor lesions, but antibiotics may be given in addition when the infection is severe and the patient has fever.
Toxic shock syndrome is a systemic infection caused by S. aureus strains which produce toxic shock syndrome toxin. The disease came to prominence through its association with tampon use by healthy women, but it is not confined to women and can occur as a result of S. aureus infection at non-genital sites.
Other common skin infections are caused by Streptococcus pyogenes (group A streptococci). The organisms are acquired through contact with other people with infected skin lesions and may first colonize and multiply on normal skin prior to invasion through minor breaks of the epithelium and the development of lesions.
Treatment with penicillin or erythromycin may be necessary to combat the infection.
C. albicans is a yeast organism always present in humans but are usually prevented from overgrowth by the indigenous microbial flora. C. albicans likes skin sites which are moist and warm and also rapidly colonizes damaged skin. Hence, the relative dryness of most areas of skin prevents the growth of C. albicans, which therefore are found in low numbers on healthy skin. C. albicans also colonizes the oral and vaginal mucosa and over-growth may result in disease in these sites. C. albicans is associated with diaper dermatitis. A study has shown that C. albicans induced lesions are remarkably influenced by pH, a lower skin pH giving less lesions (B. Runeman.Acta Derm Venereol 2000 ; 80: 421-424). Dermatophytosis, or athlete's foot, is a group of mycosis infections of the skin caused by the parasitic fungi dermophytes Dermatophytosis causes scaling, flaking, and itching of affected areas Dermatophytosis likes warm and moist environments and is typically transmitted in moist areas where people walk barefoot, such as showers or bathhouses
One way to reduce the problems with the kind of infections described above is to have a good personal hygiene However, excessive use of cleaning agents not only decreases the amount of harmful microbes, but can harm the beneficial microbial flora, again render it susceptible for pathogenic species to colonize and cause infections Alternatively, administration of lactic acid producing bacteria to the urogenital area and the skin, in order to out-compete pathogenic species and facilitate reestablishment and maintenance of a beneficial microbial flora in these areas, has been found to be a successful means to treat and prevent microbial infections
It has been suggested that lactic acid producing bacteria can be delivered via absorbent products, such as diapers, sanitary napkin, incontinence guards, panty liners and tampons, as described in, for example, WO 92/13577, WO 97/02846, WO 99/17813, WO 99/45099 and WO 00/35502
Other ways of delivering the lactic acid producing bacteria have also been suggested, such as a hygiene tissue that allows both cleaning and caring of the skin and urogenital area and delivery of probiotic lactic acid producing bacteria, for example, WO 04/060416
One way to apply lactic acid producing bacteria in sanitary articles is to disperse the bacteria in a hydrophobic carrier in order to protect them from moisture and thus a too early activation as e g described in EP 1 3 22 246 The hydrophobic carrier may be fatty acids according to EP 1 3 22 246
GB 1 282 889 discloses a deodorant composition comprising at least one calcium, aluminium, magnesium or zinc salt of an unsaturated aliphatic hydroxycarboxylic acid having at least 17 carbons It is said that the zinc salt may show a fungistatic activity It is further told that these metal salts can be combined with saturated aliphatic hydroxycarboxylic acids and unsaturated aliphatic hydroxycarboxylic acids The saturated hydroxycarboxylic acids may either be naturally saturated or derived from oxidation products of unsaturated fatty acids, such as oleic acid, ricinoleic acid, linoleic acid and linolenic acid. These unsaturated fatty acids upon mild oxidation lead to corresponding pure hydroxycarboxylic acids. Pure hydroxycarboxylic acids have very low oxidizing ability on other substances and a peroxide value close to 0 meq/kg. Other functional groups than hydroxyl functions are needed to give a fatty acid a real oxidizing ability. Examples of such functional groups are hydroperoxid and ozonide functions. However, when discussing the saturated aliphatic hydroxycarboxylic acids and unsaturated aliphatic hydroxycarboxylic acids the only effect discussed is their deodorising effect.
In view of the prior art there is still a need for sanitary articles with an improved probiotic effect.
SUMMARY OF THE INVENTION
The present invention relates to sanitary articles, such as sanitary napkins, panty liners, incontinence protectors, diapers, hygiene tissues, wherein to the article probiotic bacteria and at least one oxidized lipid has been added in order to inhibit the growth of unwanted microorganisms and give an improved probiotic effect.
It has surprisingly been found that oxidized lipids have a selective effect against Candida albicans and other unwanted microorganisms, and that a combined use of oxidized lipids and probiotic bacteria gives a very effective inhibition of Candida albicans or other unwanted microorganisms. The oxidized lipids effectively suppress the proliferation of Candida albicans and other unwanted microorganisms such as E. faecalis, E. coli and P. mirabilis while the probiotic beneficial bacteria remains essentially unaffected. The combined use of the probiotic bacteria and the oxidized lipid will thus result in a decreased number of unwanted microorganisms and further also an increased number of established probiotic beneficial bacteria in the microflora of the user of the sanitary article.
In one aspect of the invention the lipids have been oxidized under controlled conditions. Preferably the oxidized lipids have a peroxide value as measured by AOCS Official Method Cd 8-53 of at least 20, preferably at least 30 and more preferably at least 40 meq/kg.
In a further aspect said oxidized lipids are oxidized by treatment with ozone.
In one aspect the lipids are fatty acids or derivatives thereof. In a further aspect, the fatty acid derivatives are esters of fatty acids, especially triglycerides.
In a still further aspect at least part of the fatty acids and/or fatty acid derivatives are unsaturated.
In one aspect of the invention said probiotic bacteria are lactic acid producing bacteria.
In a further aspect said sanitary article comprises 105 to 1011 CFU, preferably 108 to 1010 CFU of probiotic bacteria.
According to one aspect of the invention the sanitary articles is an absorbent article such as a sanitary napkin, a panty liner, an incontinence protectors, a diaper or a tampon, wherein said absorbent article comprises an absorbent core.
In a further aspect said absorbent core comprises hydrophilic fibers treated with said oxidized lipids. In a still further aspect said hydrophilic fibers are cellulose fibers.
In one aspect of the invention it has been added at least 0.05% by weight of the oxidized lipids to said absorbent core, calculated on the total weight of the hydrophilic fibers contained in the absorbent core. In a still further aspect it has been added between 0.05 and 20% by weight, preferably between 0.2 and 15% by weight, more preferably between 0.5 and 10% by weight and most preferably between 1 and 5% by weight of the oxidized lipids to said absorbent core, calculated on the total weight of the hydrophilic fibers contained in the absorbent core.
In one aspect of the invention the absorbent article further comprises a fluid impervious backsheet, a liquid-pervious topsheet and/or one or more additional functional layers selected from: liquid receiving layers, liquid distribution layers.
In one aspect of the invention at least one oxidized lipid has been added to the topsheet and/or to at least one of said additional functional layers. In a furter aspect, at least 0.05% by weight of the oxidized lipids has been added to said topsheet or additional functional layer, calculated on the total weight of said topsheet and/or additional functional layer. In a still further aspect of the invention, between 0.05 and 20% by weight, preferably between 0.2 and 15% by weight, more preferably between 0.5 and 10% by weight and most preferably between 1 and 5% by weight of the oxidized lipids has been added to said topsheet and/or additional functional layer, calculated on the total weight of the topsheet and/or additional functional layer.
In one further aspect of the invention probiotic bacteria have been added to the topsheet.
In one aspect of the invention said sanitary articles is a hygiene tissue, such as a wet wipe, dry wipe, wash cloth, patch, towelette or napkin. In a further aspect said hygiene tissue contains between 0.001 and 15 g/g, preferably between 0.01 and 8 g/g, more preferably 0.05 g/g and 4 g/g and most preferably between 0.1 and 3 g/g of added oxidized lipids calculated on the total weight of the hygiene tissue.
DESCRIPTION OF THE DRAWINGS
Fig. 1 is a schematic plan view of an absorbent article in the form of a sanitary napkin or incontinence guard.
Fig. 2 is a cross section according to the line M-Il in Fig. 1. Fig. 3 is a schematic plan view of a hygiene tissue.
Fig. 4 shows the survival of LB931 in synthetic urine added to absorbent cores with different additions of ozonized sunflower oil.
Fig. 5 shows the survival of LB87b in synthetic urine added to absorbent cores with different additions of ozonized sunflower oil. Fig. 6 shows the survival of Ess1 in synthetic urine added to absorbent cores with different additions of ozonized sunflower oil.
Fig. 7 shows the survival of LB931 and Candida albicans in synthetic urine added to treated and untreated absorbent cores.
Fig. 8 shows the survival of LB931and C. albicans 702 in synthetic urine added to untreated absorbent cores and absorbent cores treated with 3 % ozonized olive oil.
Fig. 9 shows the survival of LB87b and C. albicans 702 in synthetic urine added to untreated absorbent cores and absorbent cores treated with 3 % ozonized olive oil. DEFINITIONS
The term "sanitary article" refers to products that are placed against the skin of the wearer to absorb and contain body exudates, like urine, faeces and menstrual fluid, and also to products that are used for cleaning and caring of the skin and the urogenital area and that also can be used to deliver probiotic bacteria and oxidized lipids to these areas. The invention mainly refers to disposable sanitary articles, which means articles that are not intended to be laundered or otherwise restored or reused as a sanitary article after use. Examples of disposable sanitary articles include wet wipes, dry wipes, feminine hygiene products such as sanitary napkins, panty liners, sanitary panties and tampons; diapers and pant diapers for infants and incontinent adults; incontinence pads; diaper inserts and the like.
The term "absorbent article" refers to products that are placed against the skin of the wearer to absorb and contain body exudates, like urine, faeces and menstrual fluid. The invention mainly refers to disposable absorbent articles, which means articles that are not intended to be laundered or otherwise restored or reused as an absorbent article after use. Examples of disposable absorbent articles include feminine hygiene products such as sanitary napkins, panty liners and sanitary panties; diapers and pant diapers for infants and incontinent adults; incontinence pads; diaper inserts and the like.
By "hygiene tissue" is meant any device for wiping, cleaning and caring of the skin and the urogenital area which also can be used to deliver probiotic bacteria and oxidized lipids to these areas, for instance a wet wipe, dry wipe, washcloth, patch, towelette, napkin, and the like.
The term "lipid" denotes all fat-soluble (lipophilic), naturally-occurring substances, such as fats, oils, waxes, cholesterol, steroids, monoglycerides, diglycerides, triglycerides, phospholipids, and others.
By "oxidized lipids" is meant that the lipids have undergone an oxidation process wherein oxygen has been introduced in the lipid molecular structure. The oxidation agent is any agent, which leads to oxidation of the lipid structure, e.g. oxygen gas, ozone or peroxides.
By "oxidized under controlled conditions" is meant that the substrate, i.e. the lipid has been oxidized to a degree wherein further oxidation caused by autoxidation from contact with air is substantially prevented. Preferably the lipids have been oxidized so that they have a peroxide value as measured by AOCS Official Method Cd 8-53 of at least 20 meq/kg.
By "probiotic bacteria" is meant live microorganisms that confer a health benefit when administered in adequate amounts to a host.
DETAILED DESCRIPTION OF THE INVENTION
Fig. 1 and 2 show an embodiment of an absorbent article in the form of a sanitary napkin or an incontinence guard 1 intended to be worn as an insert in a pair of pants. The article 1 typically comprises a liquid permeable topsheet 2, a liquid impermeable backsheet 3 and an absorbent core 4 enclosed therebetween. The article has a longitudinal direction, y, and a transverse direction, x. It has a pair of longitudinal side edges 6 and 7 and a pair of transverse edges 8 and 9.
The liquid permeable topsheet 2 can be composed of a nonwoven material, e g spunbonded, meltblown, carded, hydroentangled, wetlaid etc. Suitable nonwoven materials can be composed of natural fibers, such as woodpulp or cotton fibres, manmade fibres, such as polyester, polyethylene, polypropylene, viscose etc. or from a mixture of natural and manmade fibres. The topsheet material may further be composed of tow fibres, which may be bonded to each other in a bonding pattern, as e.g. disclosed in EP- A- 1 035 818. Further examples of topsheet materials are porous foams, apertured plastic films etc. The materials suited as topsheet materials should be soft and non-irritating to the skin and be readily penetrated by body fluid, such as urine or menstrual fluid.
The liquid impermeable backsheet 3 may consist of a thin plastic film, e.g. a polyethylene or polypropylene film, a nonwoven material coated with a liquid impervious material, a hydrophobic nonwoven material, which resists liquid penetration or laminates of plastic films and nonwoven materials. The backsheet material may be breathable so as to allow vapour to escape from the absorbent core, while still preventing liquids from passing through the backsheet material.
The topsheet 2 and the backsheet material 3 have a somewhat greater extension in the plane than the absorbent core 4 and extend outside the edges thereof. The layers 2 and 3 are connected to each other within the projecting portions 5 thereof, e g by gluing or welding by heat or ultrasonic. The topsheet and/or the backsheet may further be attached to the absorbent core by any method known in the art, such as adhesive or welding by heat or ultrasonic etc. The absorbent core may also be unattached to the topsheet and/or the backsheet.
A fastening means in the form of a region 10 of an adhesive is provided on the side of the backsheet facing away from the wearer in use. The adhesive may releasably attach to the undergarment of the wearer. A release paper 1 1 protects the adhesive region before use. The adhesive region 10 may have any suitable configuration, such as elongate or transverse strips, dots, full-coated areas etc.
In other embodiments of absorbent articles according to the invention other types of fasteners, like friction fasteners, tape tabs or mechanical fasteners like hook-and-loop fasteners etc may be used to fasten the articles to the underwear or around the waist of the wearer. Some absorbent articles are in the form of pants and therefore do not need special fastening means. In other cases the absorbent article is worn in special elastic pants without the need for additional fasteners.
The absorbent core 4 can be of any conventional kind. Examples of commonly occurring absorbent materials are cellulosic fluff pulp, tissue layers, highly absorbent polymers (so called superabsorbents), absorbent foam materials, absorbent nonwoven materials or the like. It is common to combine cellulosic fluff pulp with superabsorbents in an absorbent core. It is also common to have absorbent bodies comprising layers of different material with different properties with respect to liquid acquisition capacity, liquid distribution capacity and storage capacity. This is well-known to the person skilled in the art and does therefore not have to be described in detail. The thin absorbent bodies, which are common in today's absorbent articles, often comprise a compressed mixed or layered structure of cellulosic fluff pulp and superabsorbent material. The size and absorbent capacity of the absorbent core may be varied to be suited for different uses such as sanitary napkins, pantiliners, adult incontinence pads and diapers, baby diapers, pant diapers, etc.
It is understood that the absorbent article described above and shown in the drawings only represents one non-limiting example and that the present invention is not limited thereto, but can be used in any type of absorbent articles as defined above. Fig. 3 shows an embodiment of a hygiene tissue. The hygiene tissue 12 provided can be composed of a matrix comprising any natural or synthetic fiber, such as rayon, cellulose, regenerated cellulose, polyester, polyolefine fibers, textile and the like, or foam, nonwoven, felt or batting, or combinations thereof.
The object of the present invention is to provide sanitary articles, such as sanitary napkins, panty-liners, diapers, incontinence guards, hygiene tissues etc. suitable for absorbing bodily fluids exudates and/or cleaning and caring of the skin and the urogenital area and simultaneously release probiotic bacteria and an oxidized lipid that is to be transferred to the skin, or alternatively, in order to inhibit the growth of unwanted microorganisms in the sanitary article itself during use of the article.
It has surprisingly been found that oxidized lipids have a selective effect against Candida albicans and other unwanted microorganisms, and that a combined use of oxidized lipids and probiotic bacteria gives a very effective inhibition of Candida albicans or other unwanted microorganisms. The oxidized lipids effectively suppress the proliferation of Candida albicans and other unwanted microorganisms such as E. faecalis, E. coli and P. mirabilis while the probiotic beneficial bacteria remains essentially unaffected. The combined use of the probiotic bacteria and the oxidized lipid will thus result in a decreased number of unwanted microorganisms and further also an increased number of established probiotic beneficial bacteria in the microflora of the user of the sanitary article.
The probiotic bacteria which are suitable for use in the present invention produce acid and are non-pathogenic. There are many suitable bacteria identified herein below, although the invention is not limited to currently known bacterial species and strains as long as the above function and the objectives of the bacteria are fulfilled.
An important characteristic of these bacteria is their capability to produce acid, said acid increases the acidity of the skin mucosa which helps in preventing the growth, colonization and survival of undesired fungi and bacteria. Thus, by the mechanism of lactic acid production, these probiotic bacteria inhibit the growth of competing and harmful bacteria and fungi. Further important characteristic of said bacteria is their ability to produce hydrogen peroxide and other microbe inhibiting substances and also their ability to adhere to cell surfaces and thereby prevent adhesion of other harmful bacteria to these surfaces.
Typical lactic acid-producing bacteria useful in a microbe-inhibiting composition of this invention are all members of the Lactobacillus, Lactococcus or Pediococcus, which are efficient acid producers, and also including non-pathogenic members of the Bacillus genus, all members of the Bifidobacterium genus, and Pseudomonas limbergii, although certain species are especially preferred as described below.
Preferred members of the Lactobacillus genus include Lactobacillus acidophilus,
Lactobacillus brevis, Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus cereale, Lactobacillus delbrukeii, Lactobacillus fermentum, Lactobacillus gaserii, Lactobacillus jensenii, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus salivarius, Lactobacillus thermophilus, Lactobacillus paracasai sp. paracasai, Lactobacillus crispatus, Lactobacillus helveticus, Lactobacillus lactis, and the like.
Particularly preferred are Lactobacillus fermentum Ess-1 and Lactobacillus plantarum LB 931. Ess-1 has previously been found valuable for preventing and/or treating Candida infections as it inhibits growth of Candida albicans and several other harmful microorganisms, as disclosed in WO 2008060198. LB 931 has shown to be particularly effective for preventing and/or treating other urogenital infections, as disclosed in e.g. EP1060240.
It should be noted that although in the examples below only three Lactobacilli species have been used, these bacteria should only be seen as a model for lactic acid producing species of probiotic bacteria useful in the practice of the present invention. Therefore the below examples should not be seen as limiting for the present invention. It is intended that any acid producing species of probiotic bacteria may be used in the composition.
A sanitary article of the present invention typically comprises lactic acid producing bacteria in amounts of about 105- 1011 CFU (colony forming units) of viable probiotic acid- producing bacteria per article. The bacteria may be in the form of cells or spores which are provided in a suspension which is applied to the sanitary article which is thereafter dried. The bacteria may also be freeze dried and dispersed in a hydrophobic carrier, in order to protect the bacteria from ambient moisture, before being added to the sanitary article.
Preferably, the sanitary article will comprise about 108 - 1010 CFU per sanitary article, although these amounts may vary depending on the specific application, product formulation and intended use.
It has according to the invention been shown that oxidized lipids are very effective in reducing Candida albicans and other unwanted microorganisms. Natural animal-derived or plant-derived lipids are very often mixtures of mono-, di- and triglycerides and free fatty acids. The lipids can be purified, hydrated, refined, modified and used individually or in different mixtures. Examples of suitable lipids which originate from animals can be found in bees waxes, emu oil, lactis lipida, lanolin, shark's liver oil, lard, whale oil, butter fat and tallow. Examples of suitable lipids which originate from plants can be found in apricot kernel oil, ground nut oil, avocado oil/wax, blackcurrant seed oil, borage seed oil, Brazil nut oil, castor oil, cacao butter, cocoa butter, coconut butter, coconut oil, maize oil, cotton seed oil, rose hip seed oil, evening primrose oil, grape seed oil, linseed oil, mango seed oil, rose oil, olive oil, orange wax, palm oil, ground nut oil, rice wax, sesame seed oil, shea butter, soybean oil, sunflower oil, sunflower seed wax, peanut oil, sesame oil, safflower oil, theobroma oil, tobaccoseed oil, poppyseed oil, teased oil, kapok oil, rice bran oil, sorghum oil, crambe oil, linseed oil, perilla oil, hempseed oil, tung oil, oiticica oil, palm kern oil, sweet almond oil and wheat germ oil. Further examples of lipids are phospholipids and waxy oils, which contain esters of mono-alcohols, for example jojoba oil and seed coat wax.
Triglycerides are commonly occurring in many natural fats and oils. Most of the naturally occurring triglycerides contain a mixture of saturated and unsaturated fatty acids, while the proportion of saturated and unsaturated fatty acids varies between the different oils. This proportion can be given as the quotient: unsaturated/saturated. The unsaturated fatty acids may either be monounsaturated or polyunsaturated. The most commonly occurring fatty acids in triglycerides are palmitic acid, a saturated fatty acid, oleic acid, a monounsaturated fatty acid, linoleic and linolenic acids, which are polyunsaturated fatty acids. The composition of some common natural oils are given in Table 1 below, which is taken from Bailey's Industrial Oil and Fat products, vol.1 , editor: Daniel Swern, John Wiley & Sons Inc., New York,1979.
5 Table 1
Figure imgf000014_0001
Such oils and fats normally contain antioxidants, either naturally occurring or added by a supplier, so that autoxidation caused by contact with air is substantially prevented or delayed.
10
The lipids used in the present invention are oxidized by an oxidizing agent. Examples of useful oxidizing agents are: ozone, peroxides, oxygen gas, peroxy acids and nitrogen dioxide. For lipids containing antioxidants more powerful oxidizing agents like ozone and peroxides are required, but for lipids without any significant amounts of antioxidants, 15 oxygen or air, i.e. autoxidation under a sufficient time period, may be sufficient.
The reactivity of different lipids is dependant on the number of double bonds, i.e. the degree of unsaturation. Saturated lipids oxidize very slowly while lipids with a high degree of unsaturation oxidize more rapidly. The relative rates of autoxidation at a temperature of 20 100°C of some fatty acids (not treated with antioxidants) are found in Table 2 below and are taken from the same reference as for Table 1.
Table 2
Figure imgf000014_0002
The oxidation should preferably be performed under controlled conditions, so that after the oxidation process autoxidation is substantially prevented. Preferably the oxidized lipids should have a peroxide value as measured by AOCS Official Method Cd 8-53 of at least 20, preferably at least 30 and more preferably at least 40 meq/kg.
The lipids may be oxidized by any suitable method and by any suitable oxidation agent, for example by ozone, mixtures of ozone/air or ozone/oxygen.
At the oxidation process a series of peroxidic products may be formed, such as hydroperoxides, ozonides, diperoxides, peroxides and polyperoxides. Certain by-products may also be formed, for example ketones and aldehydes, which are less desired. These by-products may be removed by extracting the lipids with a solvent after the oxidation process. Alternatively volatile undesired substances may be removed by evaporation, for example under vacuum. A further possibility is to selectively remove said undesired substances by adsorption.
It has according to the invention been shown that pulp treated with oxidized lipids, especially ozonized triglycerides, have a significant ability to inhibit the growth of Candida albicans and other unwanted microorganisms such as E. faecalis, E. coli and P. mirabilis.
The amount of oxidized lipids added should be at least 0.05% of the total weight of the treated pulp.
The treated pulp may be mixed with untreated pulp and/or with superabsorbent material to form an absorbent core 4. An absorbent core can contain between 0.05 and 20% by weight, preferably between 0.2 and 15% by weight, more preferably between 0.5 and 10% by weight and most preferably between 1 and 5% by weight of added oxidized lipids calculated on the total weight of the hydrophilic fibers, for example pulp fibers, contained in the absorbent core.
The oxidized lipids may thus be added to the pulp, usually cellulosic fluff pulp, used in the absorbent core 4 of an absorbent article. Alternatively or in addition they may be added to the topsheet 2 or any additional functional layer contained in the absorbent article, such as liquid receiving layer, liquid distribution layer, liquid storage layer etc.
At least a part of the treated pulp fibers in the core can be distributed only to certain areas in the absorbent core 4. For example the treated pulp fibers are distributed or positioned in areas in the form of spaced apart islands. The proportion by weight of the hydrophobic microbe-inhibiting material in the aforementioned islands in the core can be 25-35 % by weight, calculated in relation to the total weight of the hydrophilic fibrous material in the core in the areas or the islands. In such areas, the proportion by weight of oxidized lipids can be higher compared with the situation in which the oxidized lipids are uniformly distributed in a core, since a greater proportion by weight of liquid-absorbent fibers is present in adjacent parts of the liquid-absorbent core in order to compensate for impaired liquid absorption by the treated pulp fibers in the areas. The treated fibers can be mixed with other fibers and/or with superabsorbent material in different proportions. The proportion of oxidized lipids should not be too high in the wetting area, because they may impair the absorption capacity of body liquid. The wetting area is located essentially in the central crotch part of the absorbent article.
in the same manner as in the absorbent core 4, the oxidized lipids can be uniformly distributed in any other layer in the absorbent article, such as the topsheet, a liquid receiving layer, a liquid distribution layer or the like. The proportion by weight of the oxidized liquid in these layers can be the same as for the absorbent core. The oxidized lipids can also be distributed in certain areas of these layers in the same way as described with respect to the absorbent core.
Depending on the kind of absorbent article, the proportion of oxidized lipids may vary.
The oxidized lipids can be added to the pulp fibers, or other fibers, in conjunction with the production of the fibers or be added in the production apparatus in which the absorbent articles are produced. The lipids may either be oxidized before being added to the fibers or after addition. In the latter case the fibers, for example pulp fibers, are treated with the lipids and the treated pulp is then reacted with the oxidizing agent, for example ozone. The ozone may then at the same time act as a bleaching agent for the pulp. The amount of oxidized lipids added may vary dependant on the intended use. For example in personal hygiene higher amounts of the oxidised lipids may be used in the urogenital area, where it is an advantage that the lipids remain on the skin, than in hand or foot wiping, where it may be desired that only small amounts of the lipids may remain.
The hygiene tissue can contain between 0.001 and 15 g/g, preferably between 0.01 and 8 g/g, more preferably between 0.05 and 4 g/g and most preferably between 0.1 and 3 g/g of added oxidized lipids calculated on the total weight of the hygiene tissue. The amounts may differ dependant on the intended use.
Upon use of the hygiene tissues the probiotic bacteria and the oxidized lipid are preferably transferred and delivered to the skin thereby serving as a skin treatment agent.
The oxidized lipids and the probiotic bacteria may be added separately or premixed to hygiene tissue. If the oxidized lipids and the probiotic bacteria are added separately they may be distributed evenly throughout the hygiene tissue. Alternatively, the oxidized lipids and the probiotic bacteria may be localized in specific areas of the hygiene tissue, especially on the surface thereof, so as to be easily released from the hygiene tissue and transferred to the skin. When the oxidized lipids and the probiotic bacteria are localized in specific areas of the hygiene tissue, the oxidized lipids and the probiotic bacteria may be added separately to the hygiene tissue on different locations of the hygiene tissue.
One or more of the following components may be added to the hygiene tissue together with the oxidized lipid: a viscosity regulating agent, a carrier for the oxidized lipid or an agent for improving the adhesion of the composition to the skin. Quaternary tensides may be used as agents for improving the adhesion to skin. Other components which may be contained in the composition are cleaning agents, skin care agents, fragrances etc. Furthermore, it is important to keep the water activity of the composition very low in order to secure the survival of the probiotic bacteria.
The lipids may either be oxidized before being added to the fibers or after addition. The ozone may then at the same time act as a bleaching agent for the pulp, in case pulp fibres are present in the wipe. The carrier material used in the hygiene tissue should be chosen so that it can hold the oxidized lipids in its porous structure and release it to the skin when the wipe is used. Examples of suitable carrier materials are fibrous materials such as tissue paper, airlaid tissue and different type of nonwoven materials. Examples of nonwoven materials are hydroentangled webs, spunbond, meltblown, thermobonded webs etc. Further examples of carrier materials are foams, nets, films etc. In the case of films the oxidised lipids may be applied between film layers and exposed when separating the film layers from each other and/or applied in formed recesses in the film.
The structure of the carrier material is important for its function to hold liquid substances. A material that is especially suitable in this respect is hydroentangled webs.
Fibres that are useful in fibrous carrier materials are pulp fibres, cotton fibres, bamboo fibres and other natural fibres, regenerated cellulose fibres such as viscose and lyocell as well as syntethic polyolefin fibres, like polyethylene and polypropylene, polyester and mixtures thereof.
For a so called wet wipe a suitable fiber composition may be a mixture of viscose fibers and polyester fibers, for example 70 wt% viscose fibers and 30 wt% polyester.
A common fiber composition in other type of wipes is a mixture of pulp fibers and polypropylene.
A suitable basis weight for a personal hygiene wipe is between 30 and 70 g/m2, preferably between 40 and 50 g/m2.
The size of the hygiene tissues may vary depending on its intended use. Examples of suitable sizes are 10x15 cm, 12x20 cm and 16x18 cm.
The composition comprising the oxidized lipids may be added to the carrier material by spraying, coating and impregnation.
If the sanitary article is an absorbent article the probiotic bacteria may be added to the topsheet, to the absorbent core or to an acquisition layer, being interposed between the topsheet and the absorbent core. The oxidized lipids and the probiotic bacteria may be added separately or premixed to the absorbent article. The probiotic bacteria may be added to a different location than the oxidized lipids or to the same location as the oxidized lipids. In order to achieve a good transfer to the user, the topsheet is preferred.
Experimental section
Ozonization of oil/fat
The ozone was generated in an Argenotox ozone generator, type GL, Hamburg, operated at a voltage of 150V an inlet oxygen flow of 63 l/h. 200 g of each tested oil/fat was treated during a time period of 2h with an ozone/oxygen flow of 0.061 g/min. The ozone concentration of the added gas was 58 g/m3.
For the strongly ozonized sunflower oil according to table 4, having a peroxide value of 276.9 meq./kg, ozone was bubbled through 50 g oil for 5.5 h. The strongly ozonized olive oil, with a peroxide value of 263.8 meq./kg, was prepared by addition of ozone to 50 g oil under 22 h.
The gas was bubbled through the oil which was contained in a vented vessel. A magnetic stirrer was used in the vessel. The solid fats were gently heated above melting temperature, after which the gas was bubbled through the liquid fats. The tested oils/fats are those stated in Table 3 below.
Table 3
Figure imgf000019_0001
The degree of oxidation was tested by determining the peroxide value according to the test method AOCS Official Method Cd 8-53 Surplus 2003. The peroxide value for both the starting oils/fats and the ozonized oils/fats was determined. The results are given in Table 4 below. Table 4
Figure imgf000020_0001
Test liquid 1 Sterile, synthetic urine to which a growth medium for microorganisms had been added. The synthetic urine contained monovalent and divalent cations and anions and urea and had been produced in accordance with the information in Geigy, Scientific Tables, vol. 2, 8th ed., 1981 , page 53. The growth medium for the microorganisms is based on two common growth media, Hook and FSA medium for enterobacteria. The pH in this mixture was 6.6.
Treatment of pulp with oils/fats
Sheets of sulfate pulp from Weyerhaeuser Inc., with the designation NB416, were impregnated with a solution of the tested oil/fat in hexane. The solution contained 43% ozonized oil/fat and 57% hexane. The solution was equally distributed over the surface of the sheets. About 5 gram of liquid was added per 5 gram of pulp. When the hexane had evaporated (after about 4 hours) the sheets contained 30% by weight oil/fat and 70% by weight pulp fibers. The treated sheets were defibrated in a Braun multimixer MX32 to produce fluff pulp. Experiment 1
Bacterial growth measurements
A homogenous mixture of fluffed pulp was prepared in the following way (Method 1 ): Untreated and treated Weyerhauser pulp (NB416) was weighed in desired proportions and put in Braun multimixer, MX32. The pulp was mixed about 30 seconds.
Absorbent cores for testing were produced in the following way (Method 2): Absorbent cores were prepared using a slightly modified sample former according to SCAN C 33:80. Fluffed pulp of the desired type(s) was weighed and a homogeneous mixture of the fluffed pulp(s) was introduced into a flow of air having a negative pressure of approximately 75mbar, through a pipe having a diameter of 10 mm and being equipped at the bottom with a metal net. The fluff pulp was gathered on the metal net and thereafter constituted the absorbent specimen. The absorbent core was compressed to a bulk within the range of 6 to 12 cm3/g.
Two different types of absorbent cores were produced; the reference cores were composed of 2.Og untreated Weyerhauser pulp (NB 416) and the test cores were composed of a mixture of 1.4g treated Weyerhauser pulp (NB 416), treated with oxidized sunflower oil (30 weight% oil), peroxide value 65.5 meq./kg, according to the method described under "Treatment of pulp with oils/fats" above and 1.Og of untreated
Weyerhauser pulp (NB 416). This means that the test cores contained 15% ozonized sunflower oil. The size of the absorbent cores was 5 cm in diameter.
The bacterial growth in the absorbent cores was measured in the following way: Bacteria were cultured in nutrient broth and diluted in test liquid 1 to the desired concentration of ca. 103 3 cfu/ml (colony forming units/ml). 10 ml of test liquid 1 containing bacteria were added to the test cores and each of the cores were placed in a sterile jar (Nunc sputum/organ jars, 100 ml), and lids was fitted on the jars. The jars was turned upside down and incubated in a warm cabinet at 35°C. After incubation for 0, 6 and 12 hours, the absorbent cores were each placed in a plastic bag with 90 ml peptone water and the content was homogenized (agitated and worked up) in a stomacker for 3 minutes. The homogenate was diluted in dilution tubes with peptone water and a microbiological culture was spread on agar plates. Slanetz Bartley agar was used for E. faecalis, and Drigalski agar for E. coli and P. mirabilis. The specimens were incubated at 350C for 1-2 days before the colonies were counted. The result is shown in Table 5, which clearly illustrates an reduction of all 3 test bacteria in the test cores after 6 and 12 hours, compared with the reference core in which all the bacteria grew well.
Table 5
Figure imgf000022_0001
mv = mean value
Experiment 2
Survival of Lactobacillus plantarum, LB931, and Lactobacillus piantarum/brevis, LB87b, in synthetic urine on treated and untreated absorbent cores
Sheets of bleached kraft pulp produced by the company Weyerhaeuser, NB416, were fluffed in a laboratory hammermill. Sheets of the same pulp grade were also impregnated with ozonized oil. 1.6 of ozonized sunflower oil with a peroxide value of 276.9 meq./kg was dissolved in 23.4 g acetone. This solution was then thoroughly distributed over a sheet of NB416, weighing 25 g. The solution ws rapidly absorbed by the pulp and seemed to be homogeneously distributed. After 4 h, the acetone h evaporated and a pulp sheet containing 6 % ozonized sunflower oil had been prepared. To another sheet, weighing 25 g, was added 10.7 g ozonized sunflower oil with a peroxide value of 276.9 meq./ dissolved in 14.3 g acetone, according to the same procedure. This resulted in a sheet containing 3i % ozonized sunflower oil.
The pulp sheets containing, 6 % and 30 % ozonized sunflower oil, respectively, were fluffed in a Braun Multimixer MX 32. The sheet was first torn by hand to pieces with a size of about 2 cm*2 cm and then about 5 g pulp at the time was agitated in the mixer at maximum intensity for about 30 s. After this treatment of the two samples, fluffed pulps with 6 % resp. 30 % ozonized sunflower oil hac been prepared.
Pads of fluffed pulp were prepared by mixing untreated, fluffed NB416 and fluffed NB416 containing ozonized sunflower oil. Each pad contained 2 g pulp and different amounts of ozonized sunflower oi
Sample 1. 2 g untreated, fluffed NB416
Sample 2. 1 ,03 g untreated, fluffed NB416 and 1 ,03 g fluffed NB416 containing 6 % ozonized sunflower oil
Sample 3. 1 ,18 g untreated, fluffed NB416 and 1 ,18 g fluffed NB416 containing 30 % ozonized sunflower oil
This means that sample 1 contained just pulp fibres, sample 2 contained 3 % ozonized sunflower oil and sample 3 contained 15 % ozonized sunflower oil. Each sample was then mixed in the Braun Multimixer for 10 s at maximum intensity to achieve homogeneous fibre mixtures. These fibre mixtures were then used for preparation of circular, 0 5 cm, pads using a PFI test piece former. Thi: equipment is described in the standard method SCAN-C 33:80. The test pieces were then compressed with a load of 16 kPa for 10 s., which resulted in a density of 10-15 cm3/g. 12 test piece of each sample were prepared.
The survival of LB931 and LB87b (Essum AB, Umea Sweden) was measured in the following way. The lactobacilli were cultured in MRS broth to stationary phase. The suspension of each strain was diluted in test liquid 1 to a concentration of about 104 - 1045 CFU/ml.
10 ml of test liquid 1 containing LB931 and LB87b respectively was added to the treated and the untreated absorbent cores, respectively, each placed in a sterile plastic jar, and the jars were covers with plastic lids. Two samples were prepared for each bacteria and absorbent core. The jars were incubated in a warm cabinet at 370C. After incubation for 0 and 4 hours, the absorbent cores were each placed in a plastic bag with 20ml saline solution and the content was homogenized (agitated a worked up) in a stomacher for 3 minutes at high speed. The homogenate was diluted in dilution tube with saline solution and the suspension was spread on Rogosa agar plates. The plates were incubated at 37°C in 5% CO2 for 2 days before the colonies were counted.
The results are shown in Fig. 4 and 5. As may be seen LB931 and LB87b survived and grew well in the untreated pad as well as in the pad treated with 3% ozonized oil. There was a small decline in growth in the pad treated with 15% ozonized oil, which may indicate that lower concentration than 15% ozonized oil is preferred to assure a maintained survival for certain probiotic bacteria.
Experiment 3
Survival of Lactobacillus ferrnentum, Ess-1, in synthetic urine on treated and untreated absorbent cores
For preparation and test of absorbent cores, see experiment 2. However, in this test only samples 1 and 2 were prepared.
Sample 1. 2 g untreated, fluffed NB416
Sample 2. 1 ,03 g untreated, fluffed NB416 and 1 ,03 g fluffed NB416 containing 6 % ozonized sunflower oil. This means that sample 2 in total contained 3% ozonized sunflower oil.
The suspension of Ess-1 was diluted in test liquid 1 to a concentration of about 1035 - 1045 CFU/ml.
The result is shown in Fig. 6. Ess-1 survived and grew well in the untreated pad and remained on Vt start level in the pad treated with 3% ozonized oil.
Experiment 4
Survival of Lactobacillus plantarum LB 931 and C. albicans in synthetic urine on treated and untreated absorbent cores
A test has been performed to evaluate the effect of ozonized oil on survival of Candida albicans and of Lactobacillus plantarum LB931. Test liquid 1 as described above was prepared for the growth measurements. Fluffed pulp was prepared according to Method 1 and absorbent cores were prepared according to Method 2. However the oxidised oil was in this case oxidised sunflower oil having a peroxide value of 276.9 mmol/kg according to the method described under "Treatment of pulp with oils/fats" with the exception that acetone was used to dissolve the ozonized sunflower oil instead of hexane. This means that the untreated absorbent core contained just pulp fibres and the treated absorbent core contained 15% ozonized sunflower oil. LB931 and Candida albicans were cultured in MRS and Todd Hewitt-broth respectively to stationary phase. The suspensions were diluted in test liquid 1 to a concentration of about 3,5x104 cfu/ml for LB931 and about 6,0x103 cfu/ml for C. albicans.
10 ml of test liquid 1 containing Candida and LB931 respectively was added to the treated and untreated absorbent cores, respectively, placed in a sterile plastic jar, and the jar was covered with aluminium foil. Two samples were prepared for each microorganism and absorbent core. The jars were incubated in a warm cabinet at 370C. After incubation for 0, 4, 6 and 8 hours, the absorbent cores were each placed in a plastic bag with 20ml saline solution and the content was homogenized (agitated and worked up) in a stomacher for 3 minutes at high speed. The homogenate was diluted in dilution tubes with saline solution and the suspension was spread on agar plates. Sabaroud-dextrose agar was used for Candida and MRS agar for LB931. The plates were incubated at 370C (in 5% CO2 for MRS plates) for 2 days before the colonies were counted.
The result is shown in Fig 7. As can be seen, the number of C. albicans had declined to zero in the treated absorbent core after 4 hours. The growth of LB931 was slightly inhibited in the treated product after 4 hours but seem to recover. It should be noted that this small inhibition of LB931 is only seen when using a high concentration of the ozonized lipid. Both LB931 and C. albicans grew well in the untreated absorbent core.
Experiment 5
Survive! of Lactobacillus plantarum LB931 and C. albicans in synthetic urine on treated and untreated absorbent cores
This test was performed to evaluate the effect of ozonized oil on survival of C. albicans and of Lactobacillus plantarum LB931.
Sheets of bleached kraft pulp produced by the company Weyerhaeuser, NB416, were fluffed in a laboratory hammermill. Sheets of the same pulp grade were also impregnated with ozonized oil. 1.6 g of ozonized olive oil with a peroxide value of 263.8 meq./kg was dissolved in 23.4 g acetone. This solution was then thoroughly distributed over a sheet of NB416, weighing 25 g. The solution was rapidly absorbed by the pulp and seemed to be homogeneously distributed. After 4 hours the acetone had evaporated and a pulp sheet containing 6 % ozonized olive oil had been prepared. The pulp sheet containing 6 % ozonized olive oil was fluffed in a Braun Multimixer MX 32. The sheet was first torn by hand to pieces with a size of about 2 cm*2 cm and then about 5 g pulp at the time was agitated in the mixer at maximum intensity for about 30 s. After this treatment of the sample, fluffed pulp with 6 % ozonized olive oil had been prepared.
Pads of fluffed pulp were prepared by mixing untreated, fluffed NB416 and fluffed NB416 containing ozonized olive oil. Each pad contained 2 g pulp and different amounts of ozonized olive oil.
Sample 1. 2 g untreated, fluffed NB416
Sample 2. 1 ,03 g untreated, fluffed NB416 and 1 ,03 g fluffed NB416 containing 6 % ozonized olive oil
This means that sample 1 contained just pulp fibres and sample 2 contained 3 % ozonized olive oil. Each sample was then mixed in the Braun Multimixer for 10 s at maximum intensity to achieve homogeneous fibre mixtures. These fibre mixtures were then used for preparation of circular, 0 5 cm, pads using a PFI test piece former. This equipment is described in the standard method SCAN-C 33:80. The test pieces were then compressed with a load of 16 kPa for 10 s., which resulted in a density of 10-15 cm3/g. 18 test pieces of each sample were prepared.
LB931 and Candida albicans were cultured in MRS and Todd Hewitt-broth, respectively, to stationary phase. The suspensions were diluted in test liquid 1 to a concentration of about 1044 cfu/ml for LB931 and about 1043 cfu/ml for C. albicans.
10 ml of test liquid 1 containing Candida and LB931 respectively was added to the treated and untreated absorbent cores, respectively, which were each placed in a sterile plastic jar. The jar was tightly covered with aluminium foil. Two samples were prepared for each microorganism and each absorbent core. The jars were incubated in a warm cabinet at 370C. After incubation for 0, 2, and 6 hours, the absorbent cores were each placed in a plastic bag with 20ml saline solution and the content was homogenized (agitated and worked up) in a stomacher for 3 minutes at high speed. The homogenate was diluted in dilution tubes with saline solution and the suspension was spread on agar plates. Sabaroud-dextrose agar was used for Candida and Rogosa agar for LB931. The plates were incubated at 370C (in 5% CO2 for the Rogosa agar) for 2 days before the colonies were counted.
The result is shown in Fig 8. As can be seen, the number of C. albicans declined to a very low value in the treated absorbent core after only 2 hours. Hence, a growth inhibiting effect on C. albicans may be seen at the low concentration of ozonized oil of 3 %. This low value remained after 6 hours. The growth of LB931 in the treated absorbent core was not affected by the ozonized oil. Both LB931 and C. albicans grew well in the untreated absorbent core.
Experiment 6
Survival of Lactobacillus plantarum/brevis LB87b and C. albicans in synthetic urine on treated and untreated absorbent cores
This test was performed to evaluate the effect of ozonized oil on survival of C. albicans and of Lactobacillus plantarum/brevis LB87b.
For preparation of the absorbent cores and the test on survival and growth, see experiment 5.
LB87b and Candida albicans were cultured in MRS and Todd Hewitt-broth, respectively, to stationary phase. The suspensions were diluted in test liquid 1 to a concentration of about 104 7 cfu/ml for LB87b and about 1047 cfu/ml for C. albicans.
The result is shown in Fig 9. As can be seen, the number of C. albicans declined to zero in the treated absorbent core after 6 hours. The survival of LB87b in the treated absorbent core was only marginally affected by the ozonized oil. Both LB87b and C. albicans grew well in the untreated absorbent core.

Claims

1 A sanitary article such as a sanitary napkin, panty liner, incontinence protector, diaper, tampon, wet wipe, hygiene tissue, said article comprising probiotic bacteria and at least one oxidized lipid
2 Sanitary article according to claim 1 , wherein the oxidized lipids have been oxidized under controlled conditions
3 Sanitary article according to claim 1 or 2, wherein the oxidized lipids have a peroxide value as measured by AOCS Official Method Cd 8-53 of at least 20, preferably at least 30 and more preferably at least 40 meq/kg
4 Sanitary article according to any of the preceding claims, wherein said oxidized lipids are oxidized by treatment with ozone
5 Sanitary article according to any of the preceding claims, wherein the lipids are fatty acids or derivatives thereof
6 Sanitary article according to claim 5, wherein the fatty acid derivatives are esters of fatty acids, especially triglycerides
7 Sanitary article according to claim 5 or 6, wherein at least part of the fatty acids and/or fatty acid derivatives are unsaturated
8 Sanitary article according to any of the preceeding claims, wherein said probiotic bacteria are lactic acid producing bacteria
9 Sanitary article according to any of the preceeding claims, wherein said sanitary article comprises 105 to 1011 CFU1 preferably 108 to 1010 CFU probiotic bacteria
10 Sanitary article according to any of the preceding claims, wherein said sanitary articles is an absorbent article such as a sanitary napkin, a panty liner, an incontinence protectors, a diaper or a tampon, wherein said absorbent article comprises an absorbent core (4).
1 1. Absorbent article according to claim 10, wherein said absorbent core (4) comprises hydrophilic fibers treated with said oxidized lipids.
12. Absorbent article according to claim 11 , wherein at least part of said hydrophilic fibers are cellulose fibers.
13. Absorbent article according to claim 11 or 12, wherein to said absorbent core
(4) it has been added at least 0.05% by weight of the oxidized lipids, calculated on the total weight of the hydrophilic fibers contained in the absorbent core.
14. Absorbent article according to claims 11 to 13, wherein to said absorbent core (4) it has been added between 0.05 and 20% by weight, preferably between
0.2 and 15% by weight, more preferably between 0.5 and 10% by weight and most preferably between 1 and 5% by weight of the oxidized lipids, calculated on the total weight of the hydrophilic fibers contained in the absorbent core.
15. Absorbent article according to any of the claims 10 to 14, wherein the article further comprises a fluid impervious backsheet, a liquid-pervious topsheet (2) and/or one or more additional functional layers selected from: liquid receiving layers, liquid distribution layers.
16. Absorbent article according to claim 15, wherein to the topsheet and/or to at least one of said additional functional layers it has been added at least one oxidized lipid.
17. Absorbent article according to claim 16, wherein to said topsheet or additional functional layer it has been added at least 0.05% by weight of the oxidized lipids, calculated on the total weight of said topsheet and/or additional functional layer.
18. Absorbent article according to claim 17, wherein to said topsheet and/or additional functional layer it has been added between 0.05 and 20% by weight, preferably between 0.2 and 15% by weight, more preferably between 0.5 and 10% by weight and most preferably between 1 and 5% by weight of the oxidized lipids, calculated on the total weight of the topsheet and/or additional functional layer.
19. Absorbent article according to any of claims 15 to 18, wherein probiotic bacteria have been added to the topsheet.
20. Sanitary article according to any of claims 1 to 9, wherein said sanitary article is a hygiene tissue, such as a wet wipe, dry wipe, washcloth, patch, towelette or napkin.
21. Hygiene tissue according to claims 20, wherein said hygiene tissue contains between 0.001 and 15 g/g, preferably between 0.01 and 8 g/g , more preferably 0.05 g/g and 4 g/g and most preferably between 0.1 and 3 g/g g of added oxidized lipids calculated on the total weight of the hygiene tissue.
PCT/SE2009/050491 2009-05-06 2009-05-06 Sanitary article with probiotic effect WO2010128906A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/SE2009/050491 WO2010128906A1 (en) 2009-05-06 2009-05-06 Sanitary article with probiotic effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE2009/050491 WO2010128906A1 (en) 2009-05-06 2009-05-06 Sanitary article with probiotic effect

Publications (1)

Publication Number Publication Date
WO2010128906A1 true WO2010128906A1 (en) 2010-11-11

Family

ID=43050263

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE2009/050491 WO2010128906A1 (en) 2009-05-06 2009-05-06 Sanitary article with probiotic effect

Country Status (1)

Country Link
WO (1) WO2010128906A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2510912A1 (en) * 2011-03-14 2012-10-17 Wolfgang Winkelmann Medical skin coating for treating dermal infections
GB2508237A (en) * 2012-11-27 2014-05-28 Emco Packaging Systems Ltd An ozone releasing wound dressing
ITRM20130065A1 (en) * 2013-02-01 2014-08-02 Massimo Formoso NEW ABSORBENT PRODUCT.
EP2901973A4 (en) * 2012-09-28 2016-06-08 Unicharm Corp Absorbent article
CN111557499A (en) * 2020-04-28 2020-08-21 创庭生物科技(上海)有限公司 Protective mask
CN111705508A (en) * 2020-07-02 2020-09-25 北京健翔嘉业日用品有限责任公司 Antibacterial coconut fat fiber for sanitary towel and preparation method and application thereof
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US11369632B2 (en) * 2017-04-05 2022-06-28 Organicare Llc Natural composition for use in gynaecology
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1282889A (en) * 1968-07-19 1972-07-26 Grillo Werke Ag Deodorant composition
US20010033838A1 (en) * 1999-08-26 2001-10-25 Sean Farmer Use of emu oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preperations
EP1273295A1 (en) * 1999-11-25 2003-01-08 Manuel-Antonio Gomez Moraleda Composition comprising ozonized oils and/or other ozonized natural and/or synthetic products and their use in pharmaceutical, cosmetic, dietetic or food supplement compositions in human and veterinary medicine
WO2004101008A1 (en) * 2003-05-13 2004-11-25 Sca Hygiene Products Ab New product
US20080300558A1 (en) * 2005-12-20 2008-12-04 Sca Hygiene Products Ab Article

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1282889A (en) * 1968-07-19 1972-07-26 Grillo Werke Ag Deodorant composition
US20010033838A1 (en) * 1999-08-26 2001-10-25 Sean Farmer Use of emu oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preperations
EP1273295A1 (en) * 1999-11-25 2003-01-08 Manuel-Antonio Gomez Moraleda Composition comprising ozonized oils and/or other ozonized natural and/or synthetic products and their use in pharmaceutical, cosmetic, dietetic or food supplement compositions in human and veterinary medicine
WO2004101008A1 (en) * 2003-05-13 2004-11-25 Sca Hygiene Products Ab New product
US20080300558A1 (en) * 2005-12-20 2008-12-04 Sca Hygiene Products Ab Article

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2510912A1 (en) * 2011-03-14 2012-10-17 Wolfgang Winkelmann Medical skin coating for treating dermal infections
EP2901973A4 (en) * 2012-09-28 2016-06-08 Unicharm Corp Absorbent article
GB2508237A (en) * 2012-11-27 2014-05-28 Emco Packaging Systems Ltd An ozone releasing wound dressing
GB2508237B (en) * 2012-11-27 2021-06-16 Emco Packaging Systems Ltd An ozone releasing wound dressing
ITRM20130065A1 (en) * 2013-02-01 2014-08-02 Massimo Formoso NEW ABSORBENT PRODUCT.
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US11633451B2 (en) 2016-03-31 2023-04-25 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US11998575B2 (en) 2016-03-31 2024-06-04 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US11369632B2 (en) * 2017-04-05 2022-06-28 Organicare Llc Natural composition for use in gynaecology
US20220362288A1 (en) * 2017-04-05 2022-11-17 Organicare Llc Natural composition for use in gynaecology
US11857570B2 (en) 2017-04-05 2024-01-02 Organicare Llc Natural composition for use in gynecology
CN111557499A (en) * 2020-04-28 2020-08-21 创庭生物科技(上海)有限公司 Protective mask
CN111705508A (en) * 2020-07-02 2020-09-25 北京健翔嘉业日用品有限责任公司 Antibacterial coconut fat fiber for sanitary towel and preparation method and application thereof

Similar Documents

Publication Publication Date Title
WO2010128906A1 (en) Sanitary article with probiotic effect
EP2081606B1 (en) Sanitary article comprising a microbe-inhibiting composition
US20040243076A1 (en) Hygiene product with a probiotic composition
RU2382655C1 (en) Adsorbing product
PL185174B1 (en) Inhibition of bacteria growth in absorptive articles by addition of other bacteria
EP2083781A1 (en) Delivery device
US20100136210A1 (en) Sanitary article comprising lactobacilli in a hydrophilic carrier
EP2229188B1 (en) Absorbent article with odour control substane
KR20060119956A (en) Absorbent products comprising a moisturizing and lubricating compositions
EP1965839B1 (en) Absorbent article
AU2004238175B2 (en) New product
US20100104615A1 (en) Absorbent article comprising lactic acid producing bacteria
WO2010074614A1 (en) Sanitary article comprising an improved delivery device
RU2441671C1 (en) Absorbing item with deodorizing substance
RU2380118C1 (en) Adsorbent product
RU2433835C2 (en) Hygienic product, which contains lactobacteria in hydrophylic carrier
MX2008006751A (en) Absorbent article

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09844433

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09844433

Country of ref document: EP

Kind code of ref document: A1